CogniSHIELD Global Launches ADVANCED Brain Health Supplement Featuring Four Key Ingredients and 12 Years of Research
CogniSHIELD Global has introduced CogniSHIELD® ADVANCED, a dietary supplement developed to support memory, recall, focus, mental processing speed and healthy cognitive function. The new formulation combines ingredients selected through neuroscience research with Cognizin® Citicoline, a branded form of citicoline that has been studied in human clinical trials. The product is intended for adults who want to take a proactive approach to supporting brain health and healthy cognitive aging.
The supplement is now available through the company’s official website, cognishield.com, and Amazon. According to the company, CogniSHIELD ADVANCED will also be the subject of a clinical study planned for early 2027. The upcoming study is expected to add to the investigation of the formulation and its potential role in supporting cognitive health.
The launch reflects the company’s focus on combining scientific research with nutritional ingredients that have been investigated for their potential effects on brain function, oxidative stress and inflammation. CogniSHIELD ADVANCED builds on research conducted by neuroscientists at Massachusetts General Hospital (MGH), who used a laboratory model designed to reproduce important biological characteristics associated with the aging brain.
By bringing together ingredients selected through this research with citicoline, CogniSHIELD Global aims to offer a formulation for adults interested in maintaining cognitive wellness as they age. However, the company’s stated goals for the supplement should be distinguished from proven clinical outcomes for the finished product, which remains subject to further study.
Neuroscience Research Behind the New Formulation
A central component of CogniSHIELD ADVANCED’s development is research conducted in the Neuroscience Laboratories at Massachusetts General Hospital. Researchers developed a laboratory model designed to recreate key biological processes associated with brain aging. The model provided a way to investigate how different compounds might influence biological pathways relevant to brain health.
As described in the scientific journal Molecular Neurodegeneration, the research program enabled investigators to evaluate more than 2,000 FDA-approved drugs and approximately 4,000 natural products for their potential effects on biological features associated with brain aging.
The large-scale screening effort helped researchers identify compounds worthy of additional investigation. Among the ingredients highlighted in the development of the original CogniSHIELD formulation were fisetin, ipriflavone and quercetin. The research also identified more than 50 additional ingredient combinations for potential further study.
This approach is significant because brain aging involves several biological processes rather than a single mechanism. Oxidative stress, inflammatory activity and changes in cellular function are among the areas researchers investigate when examining age-related changes in the brain. Laboratory models can help scientists identify compounds that may influence these processes and prioritize candidates for additional research.
Nevertheless, findings from laboratory models do not automatically demonstrate that an ingredient will produce the same effects in people. Human clinical studies are needed to evaluate the safety, effectiveness, appropriate dosage and potential benefits of a particular formulation.
CogniSHIELD Global used the MGH research as the scientific foundation for three of its featured ingredients before adding Cognizin Citicoline to develop CogniSHIELD ADVANCED.
Company Emphasizes a Science-First Approach
Yuan-Di Halverson, Ph.D., chief scientific officer at CogniSHIELD Global, said the company developed the new supplement with an emphasis on scientific evidence and research-backed ingredients.
“The research and clinical studies supporting CogniSHIELD ADVANCED’s ingredients reflect our commitment to delivering a dietary supplement with science-backed support for brain health,” Halverson said.
Halverson added that the formulation combines three ingredients identified through research at Massachusetts General Hospital with Cognizin Citicoline, which the company describes as the most clinically studied and bioavailable form of choline.
The company’s approach brings together several compounds with different research backgrounds. Citicoline has been investigated in human studies involving cognitive function, while fisetin and quercetin have attracted research interest for their antioxidant and other biological properties. Ipriflavone has a history of use in products intended to support bone health and has also been investigated in laboratory research relating to brain cells.
Combining these ingredients creates a formulation that the company intends to position within the brain health supplement market. The extent to which the combination provides benefits beyond those of individual ingredients, however, will require evidence from studies of the finished product.
Four Featured Active Ingredients for Cognitive Wellness
CogniSHIELD ADVANCED features four principal active ingredients: Cognizin Citicoline, fisetin, ipriflavone and quercetin. The company also identifies fenugreek seed powder as a specially formulated component intended to improve the bioavailability of fisetin and quercetin.
Each ingredient has a different nutritional or research background, contributing to the formulation’s overall design.
1. Cognizin Citicoline
Cognizin Citicoline is a branded form of citicoline, a compound involved in processes associated with cellular function and phospholipid metabolism. Phospholipids are important components of cell membranes, including the membranes of brain cells.
Citicoline has been investigated for its potential relationship with cognitive performance and neurological function. According to CogniSHIELD Global, Cognizin is supported by 10 human clinical trials and is the only citicoline ingredient studied in healthy adults, as described in the company’s product announcement.
Citicoline is also found naturally in the body. Dietary sources of choline-related nutrients include foods such as egg yolks, beef liver and legumes. The amount obtained from food varies according to dietary choices and overall nutrient intake.
By including Cognizin Citicoline, CogniSHIELD ADVANCED is designed to incorporate an ingredient with human clinical research into a broader formula focused on cognitive wellness.
However, evidence relating to an individual ingredient should not be interpreted as proof that the complete CogniSHIELD ADVANCED formulation delivers the same outcomes. The dosage used, the population studied and the specific measures assessed can all influence the relevance of clinical findings.
2. Fisetin
Fisetin is a plant-derived flavonoid found in several fruits and vegetables, including strawberries and apples. Flavonoids are naturally occurring compounds that have received attention for their potential antioxidant and other biological activities.
Research into fisetin has examined its possible effects on oxidative stress, inflammatory processes and cellular health. Some preclinical studies have also investigated its relationship with phosphorylated tau, commonly referred to as p-tau, a protein modification studied in connection with certain neurodegenerative processes.
According to the company’s announcement, studies have suggested that fisetin may reduce p-tau levels and produce neuroprotective effects in animal models. These findings provide a basis for further investigation, but animal and laboratory results cannot establish that fisetin prevents cognitive decline or treats neurological disease in humans.
CogniSHIELD Global states that the amount of fisetin included in its supplement corresponds to the amount found in one serving of strawberries or apples. The company incorporates the ingredient as part of its broader effort to support healthy brain aging.
The potential effects of fisetin in the finished product will need to be evaluated through appropriately designed human studies.
3. Ipriflavone
Ipriflavone is a flavonoid-related compound found in trace amounts in certain leguminous plants and soy products. It has been used for decades in products associated with bone health and has also been examined in laboratory research involving cellular function.
In the context of CogniSHIELD ADVANCED, ipriflavone was selected as one of the three original ingredients identified through the MGH aging brain research program.
The company states that ipriflavone has demonstrated the ability to improve brain cell health in laboratory models. Such findings can help researchers identify compounds for further investigation into biological processes associated with aging.
As with the other ingredients, laboratory observations do not establish that ipriflavone improves memory, attention or processing speed in people when consumed as part of this supplement. Additional clinical research would be necessary to determine whether the ingredient provides meaningful cognitive benefits at the dosage included in the formulation.
4. Quercetin
Quercetin is a naturally occurring flavonoid found in a range of foods, including red onions, fruits, vegetables and grains. It has been studied for antioxidant, anti-inflammatory and other biological properties.
Oxidative stress and inflammation are areas of interest in research into brain aging. Scientists investigate whether compounds such as quercetin can influence these processes and whether such effects might have implications for cellular health.
CogniSHIELD Global reports that quercetin reduced neuroinflammation in the MGH aging brain model. This finding contributed to the ingredient’s inclusion in the formulation.
Although laboratory research has generated interest in quercetin’s potential neuroprotective properties, its effects in humans depend on several factors, including dosage, absorption, metabolism and the health characteristics of the population being studied.
The company includes quercetin as part of its combination of ingredients intended to support healthy cognitive function. Further human research will be needed to establish the clinical significance of the formulation’s effects.
Fenugreek Seed Powder and Ingredient Bioavailability
In addition to its four principal active ingredients, CogniSHIELD ADVANCED contains fenugreek seed powder. The company says this ingredient is specially formulated with fisetin and quercetin to increase their bioavailability.
Bioavailability refers to the proportion of a substance that is absorbed and becomes available for the body to use. It is an important consideration in supplement development because the presence of an ingredient in a product does not necessarily mean that the body absorbs or uses all of it.
Plant-derived compounds can differ in their absorption and metabolism. Formulation strategies may therefore be used to investigate whether an ingredient can be delivered more effectively.
CogniSHIELD Global has incorporated fenugreek seed powder with the aim of addressing this consideration for fisetin and quercetin. The practical impact of this combination would need to be established through suitable testing of the formulation.
The company has not provided detailed results from a clinical study of the complete product in the announcement. Its planned early-2027 clinical study may provide additional information about the formulation’s performance, depending on the study design, participants and outcomes measured.
Manufacturing Standards and Product Quality
CogniSHIELD ADVANCED is supplied as a vegan, gluten-free tablet. According to CogniSHIELD Global, the product is manufactured in a Good Manufacturing Practices (GMP)-certified laboratory in North America.
Good Manufacturing Practices are designed to help ensure that products are consistently manufactured and controlled according to applicable quality standards. They address aspects of manufacturing such as production processes, documentation and quality control.
The company also states that an ISO-certified laboratory tests every product batch for potency, safety and purity. These procedures are intended to help assess product consistency and verify that batches meet the company’s quality requirements.
CogniSHIELD ADVANCED is described as containing no genetically modified ingredients, preservatives or other additives. Consumers with specific dietary requirements or sensitivities should review the full ingredient list and product label before use.
Manufacturing and testing standards are important considerations when evaluating dietary supplements. However, quality-control certification does not independently demonstrate that a supplement is effective for improving memory, focus or other cognitive outcomes.
Consumers should also consider their existing medications, medical conditions and individual nutritional needs when deciding whether to use a new supplement. Consulting a qualified healthcare professional can help determine whether a product is appropriate for an individual’s circumstances.
Availability, Pricing and Upcoming Clinical Research
CogniSHIELD ADVANCED is available for purchase through the company’s official website at cognishield.com and through Amazon.
The company lists the price at $59.99 for a one-month supply. The product is offered in tablet form, with the formulation designed for adults interested in nutritional support for cognitive wellness.
A clinical study planned for early 2027 represents another milestone in the company’s development program. Research involving the finished formulation could help provide a clearer understanding of its safety and potential effects in people.
The value of the forthcoming research will depend on factors such as the number of participants, study duration, comparison groups, dosage and cognitive outcomes measured. Results from a well-designed human study would be more directly relevant to evaluating the complete product than evidence drawn exclusively from laboratory models or individual ingredients.
Until such evidence becomes available, claims about the supplement’s ability to support memory, recall, focus and mental processing speed should be understood as intended benefits rather than established clinical outcomes.
A Growing Focus on Brain Health and Healthy Aging
The introduction of CogniSHIELD ADVANCED highlights the continuing interest in nutritional approaches to brain health. As researchers investigate the biological mechanisms associated with aging, ingredients that influence oxidative stress, inflammation and cellular function remain areas of scientific interest.
CogniSHIELD Global is positioning its new supplement around this research, combining three ingredients identified through an MGH laboratory research program with citicoline and a formulation strategy that includes fenugreek seed powder.
The product’s development also illustrates the distinction between discovering promising compounds and demonstrating that a finished supplement produces measurable benefits in people. Laboratory models can guide ingredient selection, and studies of individual compounds can provide useful background, but clinical trials of the complete formula are necessary to establish its effectiveness.
With commercial availability already underway and a clinical study planned for early 2027, CogniSHIELD ADVANCED is entering the market as a science-oriented option for consumers interested in brain health and healthy aging.
The planned study may help clarify how the formulation performs in humans and whether its combination of ingredients offers measurable benefits for cognitive function. Until those findings are available, consumers should view the product as a dietary supplement intended to support wellness, rather than as a proven treatment or preventive measure for cognitive impairment or neurological disease.
Source link: https://www.businesswire.com/
